Literature DB >> 26434412

MALAT1 long non-coding RNA in cancer.

Rei Yoshimoto1, Akila Mayeda2, Minoru Yoshida3, Shinichi Nakagawa4.   

Abstract

A recent massive parallel sequencing analysis has shown the fact that more than 80% of the human genome is transcribed into RNA. Among many kinds of the non-protein coding RNAs, we focus on the metastasis associated lung adenocarcinoma transcript 1 (MALAT1) that is a long non-coding RNA upregulated in metastatic carcinoma cells. Two molecular functions of MALAT1 have been proposed, one is the control of alternative splicing and the other is the transcriptional regulation. In this review, we document the molecular characteristics and functions of MALAT1 and shed light on the implication in the molecular pathology of various cancers. This article is part of a Special Issue entitled: Clues to long noncoding RNA taxonomy1, edited by Dr. Tetsuro Hirose and Dr. Shinichi Nakagawa.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer; MALAT1; Noncoding RNA; Splicing

Mesh:

Substances:

Year:  2015        PMID: 26434412     DOI: 10.1016/j.bbagrm.2015.09.012

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  97 in total

1.  Estradiol promotes EMT in endometriosis via MALAT1/miR200s sponge function.

Authors:  Yu Du; Zhibing Zhang; Wenqian Xiong; Na Li; Hengwei Liu; Haitang He; Qi Li; Yi Liu; Ling Zhang
Journal:  Reproduction       Date:  2019-02       Impact factor: 3.906

2.  Long noncoding RNA Malat1 is not essential for T cell development and response to LCMV infection.

Authors:  Yingpeng Yao; Wenhui Guo; Jingjing Chen; Pingting Guo; Guotao Yu; Juanjuan Liu; Fang Wang; Jingjing Liu; Menghao You; Tianyan Zhao; Youmin Kang; Xi Ma; Shuyang Yu
Journal:  RNA Biol       Date:  2018-12-04       Impact factor: 4.652

3.  ERα upregulates the expression of long non-coding RNA LINC00472 which suppresses the phosphorylation of NF-κB in breast cancer.

Authors:  Zhanwei Wang; Dionyssios Katsaros; Nicoletta Biglia; Yi Shen; Lenora Loo; Xiao Yu; Hongyan Lin; Yuanyuan Fu; Wen-Ming Chu; Peiwen Fei; Yan Ni; Wei Jia; Xiaobei Deng; Biyun Qian; Herbert Yu
Journal:  Breast Cancer Res Treat       Date:  2019-03-04       Impact factor: 4.872

4.  The possible role of Sirtuins and microRNAs in hepatocellular carcinoma therapy.

Authors:  Hedyieh Karbasforooshan; A Wallace Hayes; Nooshin Mohammadzadeh; Mohammad Reza Zirak; Gholamreza Karimi
Journal:  Cell Cycle       Date:  2020-11-09       Impact factor: 4.534

5.  Temozolomide Treatment Induces lncRNA MALAT1 in an NF-κB and p53 Codependent Manner in Glioblastoma.

Authors:  David J Voce; Giovanna M Bernal; Longtao Wu; Clayton D Crawley; Wei Zhang; Nassir M Mansour; Kirk E Cahill; Szymon J Szymura; Abhineet Uppal; David R Raleigh; Ruben Spretz; Luis Nunez; Gustavo Larsen; Nikolai N Khodarev; Ralph R Weichselbaum; Bakhtiar Yamini
Journal:  Cancer Res       Date:  2019-04-02       Impact factor: 12.701

Review 6.  Stable intronic sequence RNAs (sisRNAs): a new layer of gene regulation.

Authors:  Ismail Osman; Mandy Li-Ian Tay; Jun Wei Pek
Journal:  Cell Mol Life Sci       Date:  2016-05-04       Impact factor: 9.261

7.  Radiation-Induced Long Noncoding RNAs in a Mouse Model after Whole-Body Irradiation.

Authors:  Molykutty J Aryankalayil; Sunita Chopra; Joel Levin; Iris Eke; Adeola Makinde; Shaoli Das; Uma Shankavaram; Claire Vanpouille-Box; Sandra Demaria; C Norman Coleman
Journal:  Radiat Res       Date:  2018-01-08       Impact factor: 2.841

Review 8.  Targeting RNA in mammalian systems with small molecules.

Authors:  Anita Donlic; Amanda E Hargrove
Journal:  Wiley Interdiscip Rev RNA       Date:  2018-05-03       Impact factor: 9.957

Review 9.  Non-coding RNAs as drug targets.

Authors:  Masayuki Matsui; David R Corey
Journal:  Nat Rev Drug Discov       Date:  2016-07-22       Impact factor: 84.694

Review 10.  CCAT1: a pivotal oncogenic long non-coding RNA in human cancers.

Authors:  Yu Xin; Zheng Li; Jianxiong Shen; Matthew T V Chan; William Ka Kei Wu
Journal:  Cell Prolif       Date:  2016-05-01       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.